Target intelligence / Profile preview

Acetylcholine receptor subunit beta 1 (CHRNB1)

Target
CHRNB1
Molecular classification
Ligand-gated ion channel, Cys-loop superfamily, Receptor
01

Overview

The acetylcholine receptor beta1 subunit is a component of the muscle-type nicotinic acetylcholine receptor (nAChR), a ligand-gated ion channel that mediates synaptic transmission at neuromuscular junctions. It is essential for muscle contraction and mutations are associated with congenital myasthenic syndromes.

Other names
Acetylcholine receptor beta1 subunitAChR beta1Cholinergic receptor nicotinic beta 1 subunit
02

Mechanism of action

Agonist or antagonist binding to the acetylcholine receptor, modulating ion channel activity

03

Biological functions

Acetylcholine bindingIon channel activityRegulation of membrane potentialSynaptic transmissionNeuromuscular junction transmission
04

Disease associations

Slow-channel congenital myasthenic syndrome
05

Safety considerations

Potential for neuromuscular blockadeAutoimmune reactions targeting the receptor
06

Interacting drugs

Acetylcholine

2 more in the full profile.

Beyond the preview

Go deeper on Acetylcholine receptor subunit beta 1 (CHRNB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetylcholine receptor subunit beta 1 (CHRNB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call